Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

wsj.com - AdriĆ  Calatayud - Roche Posts Higher Sales on Growth Across Pharma, Diagnostics Units
Roche Posts Higher Sales on Growth Across Pharma, Diagnostics Units
Wall Street Journal –

reported higher sales for the third quarter on growth in its pharmaceuticals and diagnostics units, as the drugmaker works to secure approval for its new breast-cancer and multiple-sclerosis pills. The Swiss group said Thursday that third-quarter…

afr.com - Sian Powell - Second life for pharma's secret drug discovery data
Second life for pharma's secret drug discovery data
Australian Financial Review –

A new and powerful Australian artificial intelligence model can comb through data from confidential pharmaceutical trials – both failed and successful – to help big pharma companies avoid wasting their resources on already…

zerohedge.com - Tyler Durden - How The NYT Hid Big Pharma PR Titan Jack Leslie In Plain Sight
How The NYT Hid Big Pharma PR Titan Jack Leslie In Plain Sight
Zero Hedge –

New York Times reporter Sheryl Gay Stolberg wrote one of the most hilarious, misleading pieces I've seen in recent months, castigating the NIH for a new vaccine injury clinic based on a leaked statement by Jack Leslie, a senior advisor to the PR…

econotimes.com - Helena Ward - Sun Pharma Board Authorizes Up to ₹10,000 Crore in Bonds
Sun Pharma Board Authorizes Up to ₹10,000 Crore in Bonds
EconoTimes –

Sun Pharmaceutical Industries Limited (Sun Pharma) has authorized up to ₹10,000 crore in bonds, which Reuters and The Economic Times reported would refinance borrowing for its proposed Organon & Co. acquisition. The Oct. 12 board decision…

econotimes.com - Celia Rowan - Sun Pharma Shares Recover From Intraday Dip Before Oct. 30 Results
Sun Pharma Shares Recover From Intraday Dip Before Oct. 30 Results
EconoTimes –

Sun Pharmaceutical Industries Limited (Sun Pharma) shares closed Oct. 21 at ₹1,745.10 on the National Stock Exchange of India (NSE), recovering from an intraday decline ahead of the company's Oct. 30 results announcement. The Economic Times'…

newswire.ca - Groupe LSL PHARMA INC. - RESEARCH CAPITAL INITIATES ANALYST COVERAGE OF LSL PHARMA GROUP
RESEARCH CAPITAL INITIATES ANALYST COVERAGE OF LSL PHARMA GROUP
CNW –

BOUCHERVILLE, QC, Oct. 21, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma'), a Canadian integrated pharmaceutical company, today announced that Research Capital Corporation has initiated equity research coverage…

econotimes.com - Celia Rowan - Orchid Pharma Board Approves Exploring a Raise of Up to Rs 600 Crore
Orchid Pharma Board Approves Exploring a Raise of Up to Rs 600 Crore
EconoTimes –

Orchid Pharma Limited's board approved exploring a capital raise of up to Rs 600 crore, while Infosys expanded its Truist partnership, putting financing and technology work in focus for Indian investors Wednesday, Oct. 21. Orchid's authorization…

koreaherald.com - Kan Hyeong-woo - Zuellig Pharma expands cold chain capacity in Korea
Zuellig Pharma expands cold chain capacity in Korea
The Korea Herald –

Global healthcare logistics provider now has one of the largest cold chain storage facilities in Korea Zuellig Pharma Korea said Thursday it had expanded its cold chain facilities at its hub in Anseong, Gyeonggi Province, as demand for refrigerated…

marketbeat.com - Ryan Hasson - Tech Stocks Took a Hit-These 2 Pharma Stocks Are Near New Highs
Tech Stocks Took a Hit-These 2 Pharma Stocks Are Near New Highs
MarketBeat –

While attention has focused on the brutal sell-off tearing through the technology sector and the AI trade, something notable has been happening in another corner of the market. The biotech and pharmaceutical sector has held its ground and…

forbes.com - Andreas Eschbach - Why Agentic AI Is The Future Of Continuous Improvement
Why Agentic AI Is The Future Of Continuous Improvement
Forbes –

​Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Continuous improvement (CI) has always been the goal in process manufacturing. In practice, however…

marketbeat.com - Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Price Target of $44.00
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Price Target of $44.00
MarketBeat –

Shares of Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has…

independent.co.uk - Erin Keller - GLP-1 drug distributed nationwide under recall
GLP-1 drug distributed nationwide under recall
The Independent –

A nationwide recall has been issued for 23 vials of injectable medication, including a popular GLP-1 weight-loss drug, over concerns that the products may not be sterile. North Carolina-based Apothecary Pharma voluntarily recalled 22 vials of…

fool.com - Motley Fool Transcribing - Thermo Fisher (TMO) Q3 2026 Earnings Call Transcript
Thermo Fisher (TMO) Q3 2026 Earnings Call Transcript
The Motley Fool –

Vice President, Investor Relations - Rafael Tejada Chairman and Chief Executive Officer - Marc Casper Senior Vice President and Chief Financial Officer - Jim Meyer Need a quote from a Motley Fool analyst? Email [email protected] Revenue -- $12.14…

thehindu.com -  The Hindu Bureau - Row over SMA drug distribution in Keralam unwarranted, say experts
Row over SMA drug distribution in Keralam unwarranted, say experts
The Hindu –

The row over the distribution of “experimental drug” meant for “clinical trials” to spinal muscular atrophy (SMA) patients assumed political dimensions in the State, with the Opposition quick to latch on to the issue…

seekingalpha.com - Albert Anthony - Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare (ALC)
Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare (ALC)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

Receive a Daily briefing on Pharma Industry News

Get Started